Trademarkia Logo

Canada

C$
Trademark Search in Canada
Zytomics

View On IC.GC.CA

Zytomics
SEARCHED

on 16 Jan 2025

Last Applicant/ Owned by

ZytoVision GmbH

Fischkai 127572 Bremerhaven

DE

Serial Number

2315388 filed on 1st Nov 2023

Correspondent Address

MILLER IP LAW

84 Neilson DriveToronto

ONTARIO

CA

M9C1V7

Zytomics

Trademark usage description

chemicals for use in industry and science; chemicals, biochemicals, for use in the following fields: pathology, genetics, human genetics, molecular pa Read More

Classification Information

Class [001]
Chemicals for use in industry and science; chemicals, biochemicals, for use in the following fields: pathology, genetics, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology, laboratory medicine; chemicals and biochemicals for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including dna, rna and proteins; nucleic acids (including dna, rna, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, dna probes being biochemical substances, rna probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers.

Classification kind code

12

Class [005]
Pharmaceuticals and medical preparations; medical preparations for diagnostics; medical preparations for in-vitro diagnostics; pharmaceuticals, pharmaceutical preparations, medical products, medical preparations, chemical products, chemical preparations, biochemical products, biochemical preparations, for medical use; pharmaceutical, medicated, chemical and biochemicals and preparations for medical purposes for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including dna, rna and proteins; nucleic acids (including dna, rna, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, dna probes being biochemical substances, rna probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers.

Classification kind code

12

Class [009]
Scientific research and laboratory apparatus, educational apparatus and simulators; analysis apparatus for conducting and evaluating histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including DNA, RNA and proteins; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, analysis apparatus for research laboratories for measuring, testing and examining tissue, cells and biomolecules including DNA, RNA and proteins.

Classification kind code

12

Class [010]
Medical apparatus and instruments; medical instruments; medical analytical apparatus for medical purposes; automatic analyzers for medical diagnosis; physical analyzers for medical use; genetic testing apparatus for medical purposes.

Classification kind code

12

Class [035]
Business management consultancy and advisory services; operation of businesses [for others]; running of a holding company, namely business management, business administration, office functions; holding company services, namely marketing strategy, professional business and organisational consultancy and management of the business interests of others and legally independent companies; business management and organization consultancy; advisory services for business management; business administration; office functions; planning and monitoring of business developments with regard to organisational matters.

Classification kind code

12

Class [042]
Science and technology services; medical laboratory services; medical research laboratory services; development of pharmaceutical preparations and medicines; clinical research; research relating to biotechnology; scientific consultancy services; biological analysis, biochemical analysis, chemical analysis, scientific analysis; scientific research in the field of genetics and genetic engineering.

Classification kind code

12

Class [044]
Medical services; medical diagnostic services; in-vitro diagnostic services for medical and pharmaceutical use; medical services, in relation to the following fields: pathology, genetic science, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology and laboratory medicine; medical services by means of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including dna, rna and proteins; medical counseling; pharmaceutical services; pharmaceutical advice; medical and health services relating to dna, genetics and genetic testing; pathology services; genetic testing for medical purposes.

Classification kind code

12

Mark Details

Serial Number

2315388

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 16th Jan 2025		Search Recorded
Submitted for opposition 20
on 16th Jan 2025		Examiner's First Report
Submitted for opposition 223
on 16th Jan 2025		Total Provisional Refusal
Submitted for opposition 256
on 14th Jan 2025		Notification of Possible Opposition Sent
Submitted for opposition 48
on 9th Apr 2024		Agent Changed
Submitted for opposition 257
on 14th Mar 2024		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 13th Mar 2024		Formalized
Submitted for opposition 1
on 13th Mar 2024		Created
Submitted for opposition 228
on 1st Nov 2023		International Registration
Submitted for opposition 30
on 1st Nov 2023		Filed